ANTIBODY-DRUG CONJUGATE

Clinical trials for ANTIBODY-DRUG CONJUGATE explained in plain language.

Never miss a new study

Get alerted when new ANTIBODY-DRUG CONJUGATE trials appear

Sign up with your email to follow new studies for ANTIBODY-DRUG CONJUGATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Cold cap trial aims to save hair during cancer therapy

Symptom relief Not yet recruiting

This study is testing whether cooling the scalp during cancer treatment can help prevent hair loss. Researchers will enroll 102 women with advanced solid tumors who are receiving specific antibody-drug conjugate treatments. They'll compare hair loss between those who use a scalp …

Matched conditions: ANTIBODY-DRUG CONJUGATE

Phase: PHASE2 • Sponsor: Jules Bordet Institute • Aim: Symptom relief

Last updated Mar 17, 2026 12:55 UTC

ANTIBODY-DRUG CONJUGATE

Get alerted when new ANTIBODY-DRUG CONJUGATE trials appear

Cold cap trial aims to save hair during cancer therapy